Related Experiment Video

Updated: Jun 28, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.8K

Retraction of "Universal theranostic CRISPR/Cas13a RNA-editing system for glioma"

Ye Wu1,2, Yunfei Wang1, Junhu Zhou1

  • 1Tianjin Neurological Institute, Tianjin Medical University General Hospital, Key Laboratory of Post-neurotrauma Neuro-repair and Regeneration in Central Nervous System, Ministry of Education, Tianjin City, Tianjin 300052, China.

Theranostics
|April 22, 2024
PubMed

Abstract:

[This retracts the article DOI: 10.7150/thno.84429.].

More Related Videos

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

616
CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions
04:21

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions

Published on: November 1, 2024

653

Related Experiment Videos

Last Updated: Jun 28, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.8K
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

616
CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions
04:21

CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions

Published on: November 1, 2024

653

Related Concept Videos

CRISPR01:59

CRISPR

50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
CRISPR and crRNAs02:53

CRISPR and crRNAs

17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K

Articles linked to this work by shared authors, journal, and citation graph.

[Corrigendum] miR‑221/222 promote malignant progression of glioma through activation of the Akt pathway.

International journal of oncology·2026

Pharmacological induction of mitochondria-lysosome hyper-tethering elicits synthetic lethality in glioblastoma.

Cancer letters·2026

NEU1 sustains mitochondria-lysosome contacts to trigger lysosomal Cu²+/cathepsin escape and mitochondrial lysis in glioblastoma (NeuLysis).

Neuro-oncology·2026

The CGCG response assessment criteria for spinal cord gliomas.

Cancer letters·2026

Rab35 drives the malignant progression of endometrial carcinoma by regulating the nuclear translocation of β-catenin.

Experimental cell research·2026

Picomolar chloramphenicol detection by orchestrating multi-level signal systems of metal-organic frameworks-catalytic hairpin assembly-gold nanoprobes.

Talanta·2026

Radiocopper in BCMA-targeted immunotheranostics of myeloma.

Theranostics·2026

hNET-targeted [18F]MFBG PET as baseline functional imaging in newly diagnosed neuroblastoma.

Theranostics·2026

Targeted phagocytosis of TNF-α by CAR macrophages restores immune homeostasis in arthritis.

Theranostics·2026

Nano-flow intracalvariosseous infusion enables skull-to-brain delivery of BBB-impermeable molecular and nanoscale agents in mice and rabbits.

Theranostics·2026

Feedback-regulated 3D-printed hydrogel micropatch for integrated therapy of fungal keratitis.

Theranostics·2026

Membrane and soluble VTCN1 (B7H4) converge on Src signaling to mediate gemcitabine resistance in intrahepatic cholangiocarcinoma.

Theranostics·2026

Retrosternal Goitre with Retrotracheal Extension.

Indian journal of surgical oncology·2026

Retraction notice to "Improved Giza pyramids construction algorithm for Modify the deep neural network-based method for energy demand forecasting" [Heliyon 9 (2023) e20527].

Heliyon·2026

Retraction notice to "Differential game model and coordination model for green supply chain based on green technology research and development" [Heliyon 7 (2021) e07811].

Heliyon·2026

Erratum.

Revista do Colegio Brasileiro de Cirurgioes·2026

From local challenges to local solutions: Insights from the 2025 Diabetes Summit Innovation Showcase.

African journal of primary health care & family medicine·2026

Discovering search behaviour in black garden ant trajectories.

PloS one·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us